Sol is an inventor and entrepreneur with 20 years experience in medical imaging research and the co-founder of Lodestone Biomedical. He is also an Associate Professor of Engineering at Dartmouth College where he is a Member of the Translational Engineering in Cancer Research Program at the Dartmouth-Hitchcock Medical Center. Sol has over 50 publications, 2500 citations, and holds 8 US patents.
A Platform Technology for In Vivo Biomarker Monitoring
Lodestone has developed a biosensor platform for in vivo monitoring of treatment response from within the tumor-immune microenvironment. Our preclinical reader provides non-invasive measurements of cytokine levels to help drug developers accelerate their research and confirm treatment efficacy. The nanoparticle-based assay within the implantable biosensor can be adapted to measure various molecular targets.
Track Chair: Hakan Sakul, Pfizer